The global Veterinary Injectable Devices Market is set for steady growth, reaching USD 1,150.7 million by 2035, up from USD 916.6 million in 2025, at a compound annual growth rate (CAGR) of 2.3% over the forecast period, according to the latest industry analysis.
Market Overview
Growing pet ownership, escalating veterinary healthcare spending, and increasing livestock immunization initiatives are fueling sustained demand for veterinary injectable devices worldwide. As veterinarians and animal health professionals emphasize precision dosing and infection control, injectable devices such as syringes and needles remain indispensable in animal care protocols.
Technological advancements—such as safety-engineered syringes, ergonomic designs, and needle-free systems—are reshaping the market landscape, improving usability and reducing contamination risks. Additionally, regulatory frameworks promoting sterile administration and device validation are driving innovation in product development.
Key Market Highlights
- Market Size 2025: USD 916.6 million
- Projected Market Size 2035: USD 1,150.7 million
- Forecast CAGR: 2.3% (2025–2035)
- Leading Segment (2025): Syringes with 38.5% market share
- Top Growth Regions: North America, Asia-Pacific, Europe
- Major Players: Hamilton Company, Neogen Corporation, Medtronic PLC, Micrel Medical Devices SA, Allflex USA Inc.
Click Here for More Information:- https://www.futuremarketinsights.com/reports/veterinary-injectable-devices-market
Segmental Insights
Product Type: Syringes dominate with a 38.5% share, reflecting their versatility in vaccination, therapeutic, and diagnostic procedures. Manufacturers continue to enhance safety features, including auto-disable mechanisms and needle guards, ensuring compliance with infection control standards.
Material Type: Plastic devices lead with 41% share due to cost-effectiveness, lightweight design, and sterility assurance. Innovations in medical-grade plastics are enabling improved biocompatibility, supporting both single-use and limited-reuse applications.
End Users: Veterinary hospitals account for 36% of market revenue, driven by their high patient throughput and stringent adoption of advanced safety devices for treatments ranging from anesthesia to chronic disease management.
Regional Outlook
North America holds the largest share (31% in 2025) thanks to robust veterinary care infrastructure, strong pet ownership trends, and strict regulations on meat quality and animal health. The Asia-Pacific region is emerging as the fastest-growing market, driven by expanding livestock populations, government-supported vaccination programs, and increasing poultry business investments.
Competitive Landscape
The competitive landscape is shaped by strategic acquisitions and product innovations. For instance:
- ICU Medical Inc. acquired Smiths Medical (January 2025) to strengthen its injectable device portfolio.
- Covetrus Inc. expanded its technology footprint by acquiring VCP’s infrastructure (December 2024), enhancing engagement with pet owners.
Leading companies such as Hamilton Company, Neogen Corporation, and Medtronic PLC are investing in disposable devices and needle-free injection systems, focusing on user safety, scalability, and broad drug compatibility.
Growth Drivers
- Rising global expenditure on pet care and livestock health
- Increased adoption of injectable drugs for rapid therapeutic action
- Growing prevalence of zoonotic diseases requiring preventive care
- Surge in demand for disposable and safety-engineered devices
Future Outlook
The veterinary injectable devices market is poised for long-term growth as animal healthcare continues to evolve toward preventive care and advanced treatment modalities. With strong demand across veterinary hospitals and clinics and expanding opportunities in emerging markets, manufacturers are expected to prioritize cost-effective, sterile, and easy-to-use devices.
Get Sample Report: – https://www.futuremarketinsights.com/reports/sample/rep-gb-4048
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
